VANCOUVER, BRITISH COLUMBIA--(Marketwire - Sept. 27, 2012) - Calyx Bio-Ventures Inc. (TSX VENTURE:CYX) ("Calyx" or the "Company") announces that the Company's operating subsidiary, Agrisoma Biosciences Inc. ("Agrisoma"), is pleased to report a successful harvest from Agrisoma's first commercial production season.
In the spring of 2012, over 40 separate growing sites comprising 6,500 acres across the southern Prairie regions of western Canada were contracted for the closed-loop production of Agrisoma's Resonance™ brand brassica carinata ("carinata"), a non-food oilseed crop. Carinata oil is an ideal feedstock for the production of value-added products such as bio-jet fuel, renewable diesel, and biodiesel and is ideally suited to the semi-arid growing conditions of the Southern Prairies of Canada and the Northern Plains of the United States.
2012 was the inaugural year of commercial production of Resonance™ carinata. 39 growing sites were contracted for commercial feedstock production and 5 growing sites were planted for pedigreed seed production in anticipation of expanded contracting acreage in 2013. In July and August of 2012, Agrisoma hosted its first annual Crop Walk Series to provide growers and industry representatives the opportunity to learn more about Resonance™ carinata's performance in the field.
Carinata is a sustainable feedstock used for the production of biofuel and is the result of more than a decade of development efforts and advanced crop improvement efforts. Agrisoma's key markets for the Resonance™ carinata include Western Canada, the Northern Plain States and the Southeast United States.
"We are very excited about Resonance™ carinata's performance in its first commercial year," stated Hugh Notman, President and CEO of Calyx Bio-Ventures. "The crop has shown itself to be highly resilient to a variety of growing conditions and successfully withstood extreme weather seen at some of the fields."
"The strong performance of Resonance™ carinata in our first year of commercial production confirms the potential for carinata to provide new opportunities for growers in the production of a non-food feedstock for the rapidly scaling renewable fuels industry" said Steven Fabijanski, President and CEO of Agrisoma.
Resonance™ is a trademark of Agrisoma Biosciences Inc. For more information about Resonance™, contact info@agrisoma.com.
About Calyx
Calyx Bio-Venture Inc. trades on the TSX Venture Exchange under the symbol "CYX" and owns approximately one third of an operating subsidiary called Agrisoma Biosciences Inc. Agrisoma is a private agricultural biotechnology company that uses a proprietary Engineered Trait Loci (ETL) technology licensed from Calyx to commercialize a suite of industry-leading oil quality and crop improvement traits for use in energy feedstock crops. For further information about Calyx, its technology, collaborations and partnerships, please visit:
ON BEHALF OF THE BOARD
CALYX BIO-VENTURES INC.
W. Hugh Notman, President & CEO
Forward-Looking Statements: This document contains certain forward-looking statements concerning Calyx and/or Agrisoma, as well as other expectations, plans, goals, objectives, information or statements about future events, conditions, results of operations or performance that may constitute "forward-looking statements" or "forward-looking information" under applicable securities legislation. Such statements or information involve substantial known and unknown risks and uncertainties, certain of which are beyond Calyx's and/or Agrisoma's control, including general business, economic, competitive, political and social uncertainties; the delay or failure to receive regulatory approvals, the characteristics and viability for bio-fuel development, the willingness of third parties to conclude agreements with Calyx and/or Agrisoma on terms that are acceptable to management of Calyx and/or Agrisoma, and the ability of Calyx and/or Agrisoma to secure sufficient future funding to carry out all of its business plans.
Such forward-looking statements or information are based on a number of assumptions which may prove to be incorrect. In addition to other assumptions identified in this news release, assumptions have been made regarding, among other things, commodity prices, operating conditions, capital and other expenditures, and project development activities.
Although Calyx and/or Agrisoma believes that the expectations reflected in such forward-looking statements or information are reasonable, undue reliance should not be placed on forward-looking statements because Calyx and/or Agrisoma can give no assurance that such expectations will prove to be correct. Forward-looking statements or information are based on current expectations, estimates and projections that involve a number of risks and uncertainties which could cause actual results to differ materially from those anticipated by Calyx and/or Agrisoma and described in the forward-looking statements or information.
The forward-looking statements or information contained in this news release are made as of the date hereof and Calyx and/or Agrisoma undertakes no obligation to update publicly or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise unless so required by applicable securities laws or the TSX Venture Exchange. The forward-looking statements or information contained in this news release are expressly qualified by this cautionary statement.
This press release shall not constitute an offer to sell, nor the solicitation of an offer to buy, any securities in the United States, nor shall there be any sale of securities mentioned in this press release in any state in the United States in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact Information:
W. Hugh Notman
President & CEO
604-689-2495
hnotman@calyxbio.com
Calyx Bio-Ventures Inc.
Keir Reynolds
Investor Relations
778-998-9242
kreynolds@calyxbio.com